electroCore (ECOR) Debt Ratio (2020 - 2026)

electroCore's (ECOR) quarterly Debt Ratio came in at 0.43 in Q1 2026, up 22.03% quarter-over-quarter from 0.35 in Q4 2025.

electroCore (ECOR) Debt Ratio (2020 - 2026) Analysis & Trends

electroCore's Debt Ratio history runs 4 years deep, the most recent figure standing at 0.43 for Q1 2026.

On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.43 in Q1 2026; TTM through Mar 2026 was 0.43, a N/A change from a year earlier, with the FY2025 full-year figure at 0.35, changed N/A from the prior year.
Debt Ratio advanced to 0.43 in Q1 2026 per ECOR's latest filing, from 0.35 in the prior quarter.
Across five years, Debt Ratio topped out at 0.43 in Q1 2026 and bottomed at 0.3 in Q3 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	0.31
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	0.32
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	0.30
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	0.04
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	0.30
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	0.27
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	0.30
10	electroCore	56,941.08	-8.77 Mn	8.36 Mn	0.43

Historic Data

Download Data

Date	Value
Mar 31, 2026	0.43
Dec 31, 2025	0.35
Sep 30, 2025	0.30
Mar 31, 2021	0.03
Dec 31, 2020	0.03
Sep 30, 2020	0.04
Jun 30, 2020	0.03